Search clinical trials for: Hormone refractory prostate cancer
Total 132514 results
-
Centocor, Inc.CompletedProstatic NeoplasmsUnited States
-
University of Southern CaliforniaAventis PharmaceuticalsCompletedProstate AdenocarcinomaUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
INSYS Therapeutics IncNational Cancer Institute (NCI)Completed
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
Cortice Biosciences, Inc.TerminatedProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownKidney Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Prostate Cancer | Multiple Myeloma and Plasma Cell Neoplasm
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedProstatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, BiologicalFrance
-
Fox Chase Cancer CenterWithdrawn
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedKidney Cancer | Leukemia | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer | Melanoma (Skin)United States
-
Centocor, Inc.CompletedProstatic NeoplasmsUnited States, Poland, United Kingdom, Belgium, Germany, India, South Africa, Russian Federation, Austria, Netherlands
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Eisai Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Colon Cancer | Renal CancerUnited States
-
University of WashingtonSanofiCompleted
-
Northwest BiotherapeuticsWithdrawnProstate CancerUnited States
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited Kingdom
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Southwest Oncology GroupCompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerProstate CancerUnited States, South Africa
-
British Columbia Cancer AgencyAstraZenecaCompleted
-
National Cancer Institute (NCI)Completed
-
Ferring PharmaceuticalsCompleted
-
Massachusetts General HospitalUnited States Department of DefenseCompleted
-
Achieve Life SciencesCompleted
-
Kaiser PermanenteCelgene CorporationCompletedProstate CancerUnited States
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Poland, Italy, Austria, France, Denmark, Netherlands, United Kingdom, Israel, Spain, Portugal
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
AgennixTerminatedProstate CancerUnited States
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
M.D. Anderson Cancer CenterCompletedProstate CancerUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateNetherlands, United States, United Kingdom
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaboratorsUnknown
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
University of FloridaCureVacTerminated
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
Cadila PharnmaceuticalsTerminatedHormone Refractory Prostate CancerIndia
-
Alberta Health servicesAmersham Health; The Prostate Cancer Research Foundation of CanadaCompletedBone Metastases | Hormone Refractory Prostate CancerCanada
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
Alberta Health servicesPfizerUnknown